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CAPILLARY BLOOD GAS MEASUREMENT AS A NOVEL MEANS OF ASSESSING FLAP
PERFUSION IN FREE TISSUE TRANSFER.
Aaron K. Remenschneider and Douglas A. Ross (Sponsored by Dr. Clarence Sasaki). Section of
Otolaryngology, Department of Surgery, Yale University, School of Medicine, New Haven, CT.
To demonstrate that in comparison to implantable O2 microelectrodes, Capillary Blood Gas
measurements represent a reliable, accessible and easy method of identifying failing free flaps,
and furthermore, to assess post-operative free-flap monitoring techniques nation-wide,
determining the openness of surgeons to new surveillance modalities.
Groin fasciocutaneous flaps were elevated in 10 rats and following arterial or venous occlusion,
oxygen microelectrode measurements (pO2 and flow) and Capillary Blood Gas measurements
(pO2, pCO2, pH, HCO3) were obtained at 0, 10 and 20 minutes. A nine question, Internet based
survey on post-operative flap surveillance techniques was sent to the personal email addresses of
238 microvascular surgeons from around the country. Response data were collected and analyzed
utilizing an online resource.
Measurements with capillary blood gas paralleled measurements with O2 microelectrodes.
Average capillary blood gas pO2 fell from 42.72 mm Hg at 10 minutes and then to 28.67 mm Hg
at 20 minutes. Average pH fell from 7.38 to 7.33 at 10 minutes and to 7.30 at 20 minutes. Results
were statistically significant with both the paired Student’s t test and the Wilcoxon signed rank
test. 75% of survey respondents indicated that clinical assessment was more important than
available adjunctive tests in the decision to re-explore the vascular pedicle in a threatened free
flap and 56% listed pinprick with flap bleeding as an important marker of flap health in their
practice. 90% of respondents indicated they are open to new quantitative monitoring techniques.
While providing users the ability to simultaneously monitor accepted modalities of flap
surveillance, pH and pO2, the capillary blood gas is a reliable and reproducible marker of flap
tissue health. Given that no single monitoring modality enjoys a clear preference among
microvascular surgeons and that more than half of these surgeons already utilize pinprick
assessment of the flap, this study demonstrates that the capillary blood gas may be well
positioned for further study in humans.
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INTRODUCTION
Any patient receiving a diagnosis of cancer in the head and neck will be rightfully
distraught about the implications of their disease and its treatment. Composing ~3% of all
newly diagnosed cancer each year,(1) head and neck malignancies are most often
squamous cell carcinomas arising in the oral cavity, pharynx, larynx, nasopharynx or on
the scalp. Curative treatment for these cancers relies on surgery, radiation or
chemotherapy or some combination of the three, and while survival data is good relative
to other cancers, there remains significant room for improvement. In treatment of
moderate to advanced cancer, one major modality of therapy involves surgical removal of
the tumor and reconstruction of the head and neck defect with a tissue autograph. Since a
successful outcome depends on the health of the transplanted tissue and its vascular
supply, detecting early warning signs of flap failure is of utmost importance. Flaps with
compromise at their vascular pedicle can be returned to the operating room for repair of
the artery or vein if found early in the course of arterial ischemia or venous congestion.
Accordingly, postoperative monitoring of the graft is of central importance. This thesis
will report on the validation and application of a novel method of free flap autograph
monitoring.

Epidemiology and Etiology of Head and Neck Cancer
In the United States in 2008 it is estimated that 35,310 men and women will be diagnosed
with cancer of the oral cavity/pharynx and 12,250 men and women will be diagnosed
with laryngeal cancer.(1) Men are diagnosed at a rate three times as frequent as women,
although year over year trends suggest that this gap is narrowing. For patients carrying a
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diagnosis of squamous cell carcinoma of the larynx, oral cavity and pharynx, 11,350 will
die from their disease in 2008.(1) Mortality data is nearly identical among black and
white women, but mean survival time has been found to be markedly shorter in black
men when compared to white men.(2) Fortunately, annual incidence trends in head and
neck cancer are on the decline with decade length period changes between -1% and 2.7% from the 1970s to 2005.(1)
Head and neck cancers occur along the aero-digestive tract and squamous cell
carcinoma is highly correlated with the abuse of alcohol and tobacco.(3) In recent years,
public health efforts to curb tobacco use appear to have led to a decline in the overall
rates of laryngeal, oral cavity and pharyngeal cancers(1); however, given the
demographics of our aging population and their history of exposure to these carcinogens,
the health care burden of these patients is likely not to change in the next two decades.
Human papilloma virus (HPV) has is also associated with head and neck cancer, with
95% of cervical squamous cell carcinomas linked to persistent HPV infection.(4) While
our understanding of this relationship is not completely clear, it appears that HPV
infection may play a role as a carcinogen in a subset of head and neck cancer patients.

Presentation of Head and Neck Cancer
Cancers of the head and neck may go unnoticed or unappreciated at early stages because
patients can present with a constellation of symptoms seemingly unrelated to serious
disease. A detailed history and examination can properly identify the primary tumor in
95-97% of cases.(5) Patient complaints can be stereotyped by location as indicated below
-
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•

Oral Cavity – Patients may complain of non-healing ulcers or persistent masses of the
tongue, lip, buccal mucosa, floor of mouth, hard palate, alveolar ridge or retromolar
trigone. Because of the rich lymphatic drainage to the oral cavity, these patients may
also present with a mobile neck mass, usually ipsilateral to the lesion.

•

Oropharynx and Supraglottic Larynx - Because these lesions arise in areas with little
direct sensory innervation, presenting symptoms of cancers here include general
dysphagia or odynophagia. Patients may also complain of otalgia due to referred pain
via Arnold’s or Jacobson’s branch of the glossopharyngeal or vagus nerves,
respectively. Cervical adenopathy is also an extremely common presenting sign in
these patients as this area is drained bilaterally by a rich plexus of lymphatics.

•

Larynx – Classically, patients will present with hoarseness or a change in voice
quality. Patients with more advanced disease may have stridor, hemoptysis or chronic
cough.

•

Nasopharynx and Paranasal Sinus – Unilateral serous otitis media in an adult raises
concern for Eustachian tube blockade, possibly by a tumor, but these patients may
also present with a neck mass as their first sign of disease. Patients with paranasal
carcinoma often complain of nasal obstruction or epistaxis.

Cost of Head and Neck Cancer
According to recent findings in a Surveillance Epidemiology and End Result (SEER)Medicare retrospective analysis, patients with squamous cell carcinoma of the head and
neck accrue large medical bills – 25,500 dollars per year more than the costs of a
matched control without head and neck cancer.(6) These costs are reflective of the
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complexity of their care, which involves head and neck surgeons, radiation oncologists
and medical oncologists as well as inpatient and outpatient ancillary staff. Given that the
cost of treatment increases with increasing stage of disease, (primarily due to a difference
in relapse rates),(7) there are not only benefits in disease outcome, but also financial
incentives in diagnosing and treating head and neck cancer at an earlier stage. Several
large-scale primary care screening programs for head and neck cancer have been studied
in Britain through the National Institute for Health and Clinical Excellence (NICE) and
they have suggested a greater need for high-risk opportunistic screening by general dental
and medical practitioners.(8) However, it has been found that there is no cost-effective
role for imaging in the screening of primary lesions in the head and neck, even in highrisk populations.(9)

Treatment in Head and Neck Cancer
Treatment for head and neck cancer patients is often long, complex and costly.(6, 10, 11)
Workup and treatment planning are frequently undertaken by a multidisciplinary tumor
board that includes surgical, radiation and medical oncologists. Head and neck cancer is
based on the AJCC’s TNM staging scale and is correlated with tumor size, location of
origin and involvement of surrounding structures. (Appendix 1)(12)
Patients presenting with early/localized staged disease and treated with either
surgery or radiation alone enjoy five year survival rates of 62.5 percent to 99 percent,
depending on tumor site and biological factors.(1, 13) However, more than fifty percent
of all head and neck cancer patients present with locally advanced disease (stage III or
IV) and necessitate more aggressive treatment.(1) Several randomized trials report that
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these patients, whether receiving primary surgery followed by radiotherapy or induction
chemotherapy followed by radiation, have five-year survival rates of 40 percent to 50
percent.(14, 15) Because outcome data for primary radiation versus primary surgery have
paralleled each other for the past two decades, large regional variations in treatment
protocols exist in the United States.(10, 16) At this institution, locally advanced disease
may be treated primarily with aggressive surgical intervention, and when necessary, free
flap repair. Surgical treatment is also utilized as salvage therapy in patients who fail
primary radiation.

Reconstruction in Head and Neck Cancer
Reconstructing surgical defects following head and neck oncological resections is a great
challenge. This difficulty stems largely from the lack of locally available tissues and/or
the presence of surrounding irradiated tissues. Any irradiated tissues used in
reconstruction have a higher failure and fistula rate than normal.(17, 18) Thus, in order to
maximize the oncological benefits of surgery, reconstruction needs to be achieved
quickly so that patients may go on to receive adjuvant therapies as soon as possible. For
these reasons, free tissue transfer remains the best reconstructive option for many patients
with head and neck cancer.
The use of free tissue flaps in head and neck reconstruction has expanded the
opportunities for surgical resection and they are indispensable treatment options today for
patients with advanced disease. Free tissue flaps have been described from over 20 donor
sites and may include everything from skin and subcutaneous fat to muscle and bone.(19)
The most frequently utilized flaps are the radial forearm fasciocutaneous flap, the rectus
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muscular flap, the anteriolateral thigh muscle flap, the fibular bone and cutaneous flap
and the scapular bone and muscular flap. Each of these volumes of tissue is harvested in a
way to preserve its implicit vasculature and to minimize damage to tissues surrounding
the donor site. Each flap is inset at the site of the oncologic resection and its vasculature
anastomosed via microsurgery to a local artery and vein. The donor site is then covered
with a local closure or by a split thickness skin graft taken most often from the thigh.

Flap Monitoring in Head and Neck Cancer
Despite technological advances in surgery, free tissue transfer maintains a failure rate of
approximately 2 percent to 5 percent. (20, 21) Most commonly, free tissue transfer
failures result from impaired arterial or venous flow, localized to the anastomosis.
Ischemic times of greater than 6 hours results in irreversible tissue damage due to a “noreflow” phenomenon. (22-24) In a no-reflow condition, the ischemic damage of worry is
not the tissue parenchyma but the vascular network which itself collapses, thus
preventing the proper return of blood from the ischemic tissue. For free flaps, the
vascular compromise must be discovered within this narrow time frame. If this is the
case, flap salvage is an option with success rates ranging from 69 percent to 95 percent.
(20, 25, 26)
Clinical assessment as defined in the literature in free flap monitoring relates to
the observation of color, capillary refill, skin turgor, tissue edema.(27) Because clinical
assessment remains the gold standard in postoperative flap monitoring, numerous devices
recording the metabolic microenvironment (also known as ‘objective’ or ‘adjunctive’
monitoring techniques) have been proposed to aid in identifying previously undetected
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failed flaps. These include implantable Doppler flow systems, laser Doppler flow
monitors, implantable oxygen tension monitors, implantable pH probes, and even
implantable microdialysis catheters.(28-35) Because tissue oxygen tension is accepted as
a sensitive and reliable method of determining adequacy of perfusion, researchers, since
the 1980’s, have helped to develop implantable microelectrodes that may be introduced
into tissue to provide an instantaneous and constant measure of the oxygen
availability.(31, 36-40) Impairing arterial or venous perfusion in experimental models has
demonstrated a decline in the pO2 and flow as measured with these devices.(31, 37) In
humans, implantable microelectrodes have been used to appropriately identify and
salvage free flaps with impaired perfusion,(32) but due to high cost and detailed operator
training, these instruments have not been widely adopted.(31)
Oxygenation in tissues is directly related to oxygen levels in arterial blood. In
humans, the gold standard for determining oxygenation and acid/base status remains the
arterial blood gas (ABG). Repeated arterial puncture, however can lead to complications
including pain, arterial injury, thrombosis with resultant distal limb ischemia and
hemorrhage.(41, 42) Capillary blood gas (CBG) sampling is an alternate easy and
inexpensive means of measuring acid/base status with diminished risk. CBG has been
extensively studied in the pediatric/neonatal population as a less invasive determinant of
respiratory status where ABG risks are greater. Researchers have found a significant
correlation in pH, pCO2 and pO2 among ABG, venous blood gas (VBG) and CBG
measurements, and as a result a host of studies in the pediatric literature confirm the
validity of CBG in determining pH and pCO2 status of critically ill children.(43, 44)
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This thesis seeks to validate the capillary blood gas as a predictive monitor of the
metabolic microenvironment of the postoperative free flap and to determine whether
microvascular surgeons nationwide would be able and willing to supplement their current
protocols with a more objective monitoring technique.

STATEMENT OF PURPOSE AND SPECIFIC AIMS OF THE THESIS
By transferring the application of capillary blood gas from a generalized determinant of
oxygenation and acid/base status to a focused measurement of the metabolic microenvironment, our objective in this study was to show that the capillary blood gas may
represent an easy to use and reliable new method of identifying failing flaps secondary to
venous occlusion, thus supporting its use as a complement to clinical assessment.

Without a widely agreed upon standard protocol for postoperative flap monitoring and
without national data on monitoring trends in the last ten years, the purpose of this survey
was to learn how microvascular surgeons were managing patients postoperatively, assess
the number of individuals still utilizing clinical assessment as their primary gauge of flap
health and discover the openness of these individuals to new monitoring techniques.

MATERIALS AND METHODS:
1. Capillary Blood Gas Assessment of Free Flap Perfusion
This portion of the thesis was completed by Aaron Remenschneider and Greg
Lesnik (Otolaryngology resident) with technical assistance from Dr. Peter Herman,
neurophysiology.

13

After receiving Institutional Animal Care and Use Committee (IACUC) approval, 10
male Sprague Dawley rats weighing roughly 300 g were purchased. All animals were
housed in accordance with the Yale Animal Committee standards in the preoperative time
period.

During the experiment, animals were anesthetized with an intraperitoneal

injection of ketamine 90mg/kg and xylazine 5mg/kg body weight. Level of anesthesia
and respiratory status were continually monitored.

Repeat injections of ketamine

45mg/kg and xylazine 2.5mg/kg body weight were given for animal arousal prior to
completion of the study. Animals were then placed on a heating mat warmed to 37.5
degrees Celsius.

Core body temperature was continually measured via a rectal

thermometer. Clean techniques were employed as sterility was not essential. Rats were
euthanized at the completion of each experiment via lethal injection of pentobarbital at
150mg/kg per IACUC protocol.

Surgical Procedure
Bilateral abdomen and groin sites were shaved. A groin fasciocutaneous flap was then
elevated and completely detached from surrounding tissues ranging vertically from the
costal cartilage to mid-thigh and horizontally from just lateral to midline to the axillary
line. The epigastric artery and vein were then carefully identified and followed to their
insertion on the femoral vessels. Using an operating microscope, the sheath of the
epigastric vessels was entered, epigastric nerve divided and artery and vein separated.
The femoral sheath was similarly isolated. All flaps revealed a visible arterial pulse
along the length of the epigastric artery post-operatively. The flap was then fastened to

14
the abdomen of the rat to prevent movement and ensure warming. Following completion
of experimentation on one side a contralateral groin fasciocutaneous flap was then
elevated in the same manner.
Venous clamping was performed by placing a microclamp around the epigastric
vein just proximal to its insertion on the femoral vein under direct microscopic
visualization. Care was made not to contact or stretch the artery. Proper placement was
confirmed by visual lack of blood distal to the clamp and visualization of a persistent
pulse in the epigastric artery. Arterial clamping was performed by similarly placing a
microclamp around the epigastric artery. Successful clamp placement was confirmed by
lack of pulsation distal to the clamp.

Oxygen Microelectrode Measurements
Bare Fibre pO2/Temperature Sensor type microelectrodes with a tip diameter of 4um
were used (Oxford Optronix OxyLab, Oxford, UK). Microelectrodes were attached to
the OxyLite/OxyFlo combined channel monitor for interpretation (Oxford Optronix
OxyLab, Oxford, UK). Continuous measurements of pO2, flow and temperature were
measured and recorded on a desktop computer using Spike2 software (Cambridge
Electronic Design, Cambridge, UK).

Tissue oxygen levels are determined by the

flourescence quenching principal where bursts of LED light transmitted via fiberoptics
excite a platinum based dye in the electrode tip, resulting in emission of fluorescent light
which is absorbed by local oxygen molecules. The difference between absorbed and
measured reflected light represents local oxygen tension. Tissue flow is determined via
Laser Doppler Flowmetry [LDF] where light from the probe tip is projected into the
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tissue, scattered and then reabsorbed by a sensor. Properties of reflected light from
erythrocytes and stationary tissues differ, representing the Doppler shift, and can be
interpreted as local flow over time by the OxyFlo monitor. The numeric calculation of
LDF is based on the concentration of local red blood cells and the velocity at which they
travel. Local temperature is determined by an attached thermocouple transducer.

Capillary Blood Gas Measurements
CBG measurements were obtained using heparanized capillary tubes and an ABL5
Capillary Blood Gas Monitor (Radiometer Copenhagen, Copenhagen Denmark).

Capillary Blood Gas Assessment of Free Flap Perfusion: Experimental Protocol
A. Tissue Oxygen Tension:
Using stereotactic manipulators, the oxygen microelectrode was inserted into the
fascia to a depth of approximately 1mm. Electrodes were consistently inserted 5mm
lateral to the split in the epigastric pedicle. Continuous readings of pO2, flow and
temperature were confirmed and recorded.

Flaps were allowed to equilibrate for

approximately 20 minutes or until steady state values were obtained for all 3 parameters.
Venous (n=4 ) or arterial (n=3 ) clamping was then performed as previously mentioned.
Measurements were continually recorded for 20 minutes. Due to technical difficulties
successful readings were obtained from 5 flaps following occlusion: venous (n=3),
arterial (n=2).
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B. Capillary Blood Gas Measurements:
Flaps were allowed to equilibrate for 20 minutes following surgery.

CBG

measurements were then obtained via the following manner. Under direct microscopic
visualization, the epigastric vein adventitia was grasped using Jewlers forceps. A 30
gauge needle with attached heparinized 1cc syringe was then carefully used to cannulate
the epigastric vein. Approximately 100 microliters of blood were then aspirated directly
from the vein. Blood samples were then transferred into a heparinized capillary tube and
inserted into the ABL5 blood gas machine for measurement of pH, pO2 and pCO2.
Further blood loss from the puncture site was prevented by applying gentle pressure
using a cotton tipped applicator.
In the experimental arm, following venous occlusion, repeat CBG measurements
were obtained at 10 and 20 minutes. CBG measurements were obtained in a similar
manner by again cannulating the epigastric vein with a 30 gauge needle distal to the
microclamp. Approximately 100 microliters of blood were gently aspirated directly from
the vein within a 1 minute time period. Adequate perfusion was confirmed prior to
obtaining blood samples by the visible presence of a pulse in the epigastric artery leading
to the flap. CBG readings obtained with less than 100 microliters of blood produced
erroneous results and were therefore immediately repeated by reaspirating a sufficient
sample from the epigastric vein. Due to technical constraints largely stemming from the
small caliber of the epigastric vein and inherent trauma from repeated cannualization
several data points were missed.
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Capillary Blood Gas Assessment of Free Flap Perfusion: Analysis of Data
CBG measurements were recorded and the values of pO2, pH and pCO2 as well as HCO3
(calculated: Henderson Hasselbalch equation) at 0, 10 and 20 minutes following venous
clamping in all eight flaps. Data on average CBG measurements or standard deviations
for pH and pO2 are not available for an a priori power analysis; thus, using sample sizes
reported in the literature for similar research(31, 33, 34, 37) and a post hoc power
analysis, we reached power over 95 percent in both pH and pO2 samples. Changes from
pre-clamp controls were statistically evaluated using a two-tailed paired Students t test
and the Wilcoxon signed rank test. Statistical significance was defined as a P value
<0.05. Data were analyzed using SPSS software and with the support of Yale University
Statistics Laboratory.

2. Yale National Survey of Free Flap Monitoring Technique
This portion of the thesis was completed by Aaron Remenschneider, under mentorship
from Dr. Douglas A. Ross, Section of Otolaryngology.

Development of the Survey
After consulting the small body of literature on institutional and surgeon use of various
flap monitoring techniques, a library of common questions used in these surveys was
constructed. ‘Clinical Assessment’ techniques, also known as subjective monitoring
techniques were differentiated from ‘Objective’ monitoring techniques that rely on a
specified and measured parameter of the tissue. Monitoring devices and techniques
included were those found in the literature as well as recently reported innovations from
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2002-2007. Surgeons were asked whether they preferred “clinical assessment’ to
‘objective’ monitoring. They were also asked whether they would be open to new
monitoring devices, if they worked at resident staffed hospitals and who was responsible
for post-operative care of patients with free flaps. Additionally, the survey asked about
the volume of reconstructive cases, whether costs were a consideration in monitoring
technique and whether staff training was a barrier to new surveillance practices. All
questions were multiple choice and allowed respondents to select more than one response
where appropriate. Each question also allowed for both write in responses and
commentary on the question.

Distribution of the Survey
The survey was built with the help of the Professional edition of the online survey
creation tool, SurveyMonkey (SurveyMonkey.com Corporation, Portland, OR). Contact
information for reconstructive surgeons from the 200 largest head and neck
reconstructive centers was obtained from Chris Ubinger of Metronic Corporation. 238
email addresses were obtained and entered into the online survey database. An initial
email with a short introduction of the study’s purpose introduced the online survey
followed by a web-link to direct participants to the SurveyMonkey website. The online
survey was open for response for 30 days. One follow up email was sent to nonrespondents at the two-week mark. Only one response per surgeon was accepted. Overall
response rate was 42% (99/238).
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Collection of Survey Data
All survey data was collected with the support of SurveyMonkey Professional edition
(SurveyMonkey.com, Portland, OR), which allows for the creation of charts, graphs and
analysis by response type.

RESULTS:
1. Capillary Blood Gas Assessment of Free Flap Perfusion
Oxygen Microelectrode, Venous Clamping
Mean oxygen tension prior to venous clamping was 28.53 mmHg with a mean
flow of 317 (Table 1). A clear steady state without fluctuations in pO2 or flow were
observed in all experiments at 20 minutes post-procedure. Venous clamping resulted in a
gradual decline in pO2 across all time points. At 5, 10 and 15 minutes mean pO2 was
23.73 mm Hg, 17.50 mm Hg and 16.26 mm Hg, respectively. Similarly venous clamping
resulted in decreased flow across all time points. At 5, 10 and 15 minutes mean flow was
288, 280 and 249 respectively. Average decline in pO2 from control at 15 minutes was
12.27 mm Hg. Figure 1 demonstrates the steady state pO2 at 20 minutes and the gradual
decline in both pO2 and flow following venous clamping.

Arterial Clamping
Mean oxygen tension prior to arterial clamping was 18.85 mm Hg with a mean flow of
497.5 (Table 1). Arterial clamping resulted in a rapid decline in pO2 from steady state
values. Similarly, the 5 minutes mean flow decreased from 497 to 153. Figure 2
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demonstrates the steady-state pO2 at 20 minutes and the rapid decline in pO2 and flow
following arterial clamping in one experiment.

Capillary Blood Gas Measurements:
Serial CBG measurements at control and over time following venous clamping may be
found in Table 2. Mean pO2 prior to venous clamping was 42.71 (+/- 5.12) mm Hg.
Following venous clamping, mean pO2 measurements at 10 and 20 minutes declined to
31.57 (+/- 7.83) mm Hg and 28.67 (+/- 6.28) mm Hg, respectively (Figure 3). Subjecting
the data to a two tailed, paired Student’s t test, this negative change in pO2 over the
course of the first 10 minutes was statistically significant at the P < 0.05 level (t(5) =
3.733, *P = 0.014, 95% CI = (3.74, 20.26)) (Table 3), and the decline continued over the
following 20 minutes (t(4) = 13.870, *P < 0.001, 95% CI = (14.72, 22.08)). The
Wilcoxon signed rank test demonstrated CBG successfully detected falling pO2 in seven
of seven flaps at 10 minutes postclamp (P < 0.001). This was also true at 20 minutes
when six of six pO2 values had dropped (P < 0.001).
Mean pH prior to venous clamping was 7.38 (+/- 0.04).

Following venous

clamping pH measurements at 10 and 20 minutes decreased to 7.33 (+/- 0.05) and 7.30
(+/- 0.04), respectively (Figure 2). The negative change in pH during the first 10-minute
period was statistically significant at the P < 0.05 level using the Student’s t test (t(6) =
2.997, *P = 0.024, 95% CI = (0.01, 0.16)) (Figure 4). The Wilcoxon test showed CBG
detected falling pH in six of seven flaps at 10 minutes (P = 0.031), and in five of six flaps
at 20 minutes (P = 0.062).
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Mean CO2 and HCO3 prior to venous clamping were 41.13 (+/- 7.68) mm Hg and
23.38 (+/- 3.11) respectively. Following venous clamping pCO2 decreased at 10 minutes
to 39.00 (+/- 9.80) mm Hg and had increased at 20 minutes to 43.50 (+/- 6.28) mm Hg.
HCO3 decreased from control at 10 and 20 minutes to 21.16 (+/- 3.66) and 21.17 (+/6.11). Neither parameter showed significant changes over time (Table 3). The Wilcoxon
test did not find significance for the changes in either CO2 or HCO3.

2. Yale National Survey of Free Flap Monitoring Technique
Respondents
An electronic invitation to participate in the Yale Free Flap Monitoring Survey
was sent to 238 individuals at academic and private practice medical centers nationwide.
Of the 238 distributed, 99 surveys were completed online for a response rate of 42
percent. All 99 of those who started the survey completed it. 82 of the 99 or 84.5 percent
indicated that they worked in academic institutions staffed with residents (Figure 5). 65.7
percent of respondents stated that nurses provide the majority of free flap monitoring
post-operatively, while 23.2 percent stated it was resident house-staff that did the
majority of monitoring (Figure 6). Attending surgeons and microvascular fellows were
found to be less frequently involved in flap monitoring. Nurses were found to provide the
majority of postoperative flap care and surveillance regardless of whether the surgeon
worked at an academic center or in a private group. 33 percent of respondents perform
more than 50 free flap reconstructions per year while 45.5 percent perform less than 30
per year (Figure 7). Respondents not working in academic medical centers tended to
perform fewer free flaps per year than those in academic centers (Figure 8).
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Monitoring Technique
All respondents indicated that they utilize clinical assessment in postoperative flap
surveillance. At 98 and 97 percent, nearly all surgeons use capillary refill and flap color
as markers of flap health, respectively (Figure 9). Three respondents commented that
subjective temperature (taken with the back of a knuckle) was also an important clinical
assessment technique used in their practice. 98 percent of respondents also use adjunctive
measures to monitor flap health. 55.7 percent employ pin-prick tests, 44.3 percent use
laser Doppler and 21.2 percent use the hand held Doppler ultrasound (Figure 10). Other
adjunctive monitoring techniques were used with lower frequency. When asked to
prioritize clinical assessment or adjunctive testing, 74.7 percent preferred clinical
assessment as described in question 1 of the survey (Figure 11). 15 percent indicated that
they rely heavily on both.
When separated by institutional affiliation, 60 percent of academic microvascular
surgeons indicated they use pin-prick assessment while only 26.7 percent of private
reconstructive surgeons do (Figure 12). There is also a wider distribution of techniques
among private surgeons and higher percent (30%) use temperature monitoring whereas
only 10 percent of academic surgeons use this. Private microsurgeons are also twice as
likely to rely on adjunctive monitoring tests in the decision to take a flap back for
revision when compared to academic microvascular surgeons.

Monitoring Staff and Openness to New Technique
89.9 percent of respondents suggested that they would be open to different monitoring
techniques (Figure 13), and 67.7 percent indicated that staff training would not be a
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barrier to the implementation of new monitoring technologies (Figure 14). If a new
monitoring device was to be considered, 67.7 percent of respondents stated that the
expense of the device would be a factor into their willingness to adopt the piece of
equipment (Figure 15). These did not differ significantly between academic and private
microvascular surgeons.

DISCUSSION:
For many patients undergoing head and neck oncologic resection free tissue transfer
remains the best reconstructive option. Despite technological advances, flap failure rates
due to arterial and venous thrombosis still approximate 5%.(20, 21) Studies have clearly
shown tissue failure from ischemia occurs in two parts: acutely due to the initial hypoxia
with ensuing acidosis and later due to reperfusion injury more commonly referred to as
no-reflow phenomenon.(22-24) Research has demonstrated that the no-reflow
phenomenon may occur in as little as 6 hours.(22) If flap perfusion is found to be
impaired prior to this critical time, flap salvage is an option with reported success rates
ranging from 69- 95%.(20, 25, 26) Because of the narrow window of time available to
correct impaired perfusion, flap surveillance in the post-operative time period is
paramount.

Adjunctive Monitoring Techniques
Numerous postoperative flap-monitoring techniques have been developed and trialed
over the years; however, most harbor limitations, thus curbing their utility in practice.
The last surveys conducted of reconstructive centers over 10 years ago clearly
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demonstrated that no one technique is commonly employed and that clinical assessment
remains the gold standard for monitoring flaps post-operatively.(23, 27, 45) Adjunctive
surveillance strategies currently used target 1 of 3 physiologic aspects of the flap: flow,
temperature or oxygen tension. Tissue flow may be monitored primarily in the pedicle
using hand held Doppler ultrasound probes or implantable Doppler flow systems (28) or
flow may be monitored in smaller vessels within the tissue using laser Doppler
flowmetry.(25, 29) Results and opinions on the effectiveness of these techniques however
have varied.
Directly measuring oxygen tension within tissues is another accepted technique
for monitoring flap perfusion. In this experiment flap failure due to arterial or venous
occlusion was observed in the relatively short time frame of 10 and 15 minutes.
Furthermore, the differences in the measurement of flow by oxygen microelectrode
recorded two clearly distinct patterns between arterial and venous compromise (Figures 1
and 2). These results are consistent with experiments done in humans that successfully
identified impaired perfusion, (31, 32) and our experience with the probes validated the
difficulty of operating and interpreting data from the microelectrode. While
distinguishing between arterial and venous compromise is helpful, most studies suggest
clinical assessment can quickly identify arterial compromise as distinct from venous
congestion.(20, 23, 27, 45) Unfortunately, the major limitations of the microelectrode
technique remain the costs and the fragility of the oxygen probes.
One early monitoring technique attempted to directly analyze the acid base status
of the flap by following pH with an implantable probe.(33, 34) With more advanced
technology today, we are now able to directly monitor the physiologic milieu of the
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transferred tissue, observing for changes in biochemical markers as evidence of
ischemia.(35) While the effectiveness of such experimental techniques has been validated
in highly controlled and small studies, the costs, both economic and practical remain
high.
Reported estimates of proposed monitoring devices include the laser Doppler
flowmeter ($10,500 + 1200/year),(25) the Microdialysis catheter and analyzer ($26,000 +
350/patient),(35) or the oxygen microelectrodes ($300-$400/use/patient).(31) We can
contrast that with the cost of the capillary blood gas, which is dependent only on the
equipment necessary to obtain the sample and analyze the result: a 20 gauge needle (~3
cents), a heparinized capillary tube (~5 cents), and the capillary gas machine (nearly
ubiquitous in hospitals today).

Capillary Blood Gas in the Assessment of Flap Perfusion
In this experiment, postocclusive changes in oxygen tension and pH were detected with
capillary blood gas analysis. Raskin and colleagues suggest that continuous monitoring of
pH after selective occlusion of the epigastric vessels will result in predictable falls in pH
measurements over time with the ensuing acidosis.(33, 34) The results from our
experiments paralleled these falls in pH and suggest that CBG is a sensitive indicator of
acidosis and cellular hypoxia. The observed changes in pH are likely due to increasing
lactate levels as cells shunt the products of glycolysis towards anaerobic respiration with
decreasing available O2.(46) Changes in measured pO2 values via CBG following venous
occlusion in our experiment were statistically significant and directly mimicked the
changes observed using the oxygen microelectrode system (Tables 1 and 2). The pCO2
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and calculated HCO3 levels did not show statistically significant changes over time in this
model (Table 3). While cellular physiology would predict rising pCO2 in congested flaps,
local HCO3 from arterial blood may have buffered this rise, blunting our observed pCO2
trends over 20 minutes. Larger and consistent changes in pCO2 may be observed in flaps
followed for longer periods.

Limitations
Rat groin flaps with epigastric pedicles have long been used to simulate fasciocutaneous
pedicle and free flaps.(47, 48) The elevation of the entire flap, leaving only the vascular
pedicle allows simulation of arterial clotting or venous thrombosis, with concurrent
preservation of inflow or outflow from the flap.

This manipulation creates a flap

microenvironment similar to failing fasciocutaneous free flaps in humans. Because of the
urgency required to salvage a failing flap, oxygen tension has often been suggested as an
ideally sensitive measure of flap health. Several studies have shown oxygen tension to be
a reliable indicator of flap perfusion.(37, 49-51) However, measured values of the partial
pressure of oxygen in the tissue varies based on sampling site, distance from vessel
insertion, warmth, and degree of rubbing.(46, 52, 53) Keeping these principles in mind,
our study design attempted to ensure uniform warmth, uniform oxygen electrode
placement and minimal irritation to both the flap and vascular pedicle.
While our original goal had been to measure flow and oxygen tension with the
microelectrode and simultaneously sample serial capillary blood gases from the groin
flap skin, we were limited by both the fragility of the microelectrode and the inadequate
volume of blood available from local tissues upon laceration. By separating our
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procedure into two steps, our pO2 and Doppler flow readings from the microelectrode
demonstrated a healthy pedicle flap with successful arterial and venous clamping
technique (Figures 1 and 2). Furthermore, it indicated the appropriate postoperative flap
recovery time was 20 minutes. This ensured a stable, baseline flap perfusion in the CBG
model, and confirmed that reliable control values could be taken with confidence prior to
vessel perturbation.
Because of the limitations of flap size, skin thickness and inadequate local flow
parameters, adequate capillary blood gas samples could only be obtained via epigastric
vein cannulation.

This was primarily a result of the small size (3cm x 3cm) and

constrained blood flow volume to the rat flap. While this technique does not directly
simulate tissue sampling, it does provide valuable information on the microenvironment
of the flap. Experimentation in an animal model with a larger flap size (ie: pig) or direct
sampling from pin-prick assessment in humans would clearly allow adequate blood for
the capillary blood gas. While extrapolation of our data would suggest that measured
changes in pH and pO2 from venous samples should also be observed from samples taken
directly from the tissue, this can not be proven in this study. Importantly, it was our
observation that it was not the absolute values of pH and pO2 that were predictive, but
instead the changes between values taken over time.
The response rate of our survey was somewhat limited at 44%, with 85% of
respondents working at resident staffed hospitals. Given that our database of contacts was
cited to be a roughly 70% academic and 30% private, there was a greater likelihood of
response among academic surgeons. Unfortunately our survey was conducted
unknowingly on the heels of another national survey of the same kind and it is possible
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that some recipients suffered from survey fatigue. Furthermore, the contacts were
obtained from Chris Ubinger, a representative from the industry side of medicine, who
compiled the list from the 200 most active reconstructive centers. Since we did not
capture from the entire universe of reconstructive surgeons, we may have missed
important constituents who do not practice in ways paralleling our respondents.
While most head and neck oncologic resections and reconstructions are carried
out in an academic center, the underreporting from non-academic surgeons may have
skewed the survey results. This bias may be evident in the perceived surgeon openness to
new techniques and availability of support staff for flap monitoring.

Application of Capillary Blood Gas in Practice
It is commonly stated that the ideal free-flap surveillance technique will be reliable, user
friendly, inexpensive and consistent.(19) As of yet, no technique satisfies all these
criteria. It was our objective to evaluate the capillary blood gas in this capacity, because
CBG currently fulfills these criteria in the pediatric/neonatal care setting by virtue of
being minimally invasive, inexpensive, and reliable. The measurements of pH, pCO2, and
pO2 are easily obtained and have proven highly correlated among ABG, VBG and
CBG.(43, 44) A simple prick of the flesh provides several drops of blood that can be
drawn into a capillary tube and analyzed with either a hand-held or lab-based blood gas
machine, usually located near neonatal or cardiac units in-house. Pricks can be performed
as needed or on a standardized schedule to chart oxygen and acid/base status over time.
With 55 percent of survey respondents noting that they use pinprick and bleeding
rate already as an adjunctive flap monitoring technique, the act of collecting the blood in
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a capillary tube for blood gas analysis comes at little cost to the patient or health
provider. In 1995, Urken described clinical assessment by an experienced microvascular
surgeon as the most effective means of surveillance.(27) Unfortunately, given the
nation’s volume of head and neck cancer, not all patients are able to receive care at large
cancer hospitals, and this was demonstrated in the survey - 45% of free flaps are
performed at low volume centers (performing < 30 flaps/year). While success rates for
free tissue transfer are widely reported above 95%(19, 54) this success has been
repeatedly shown to be correlated with the experience of the surgeon.(20, 26) If clinical
assessment is to continue as the gold standard for flap monitoring, then individuals at low
volume centers will be at a distinct disadvantage. Thus the question is whether the
capillary blood gas can help detect flap failure when clinical observation cannot, and
certainly this is most relevant for microvascular surgeons performing few flap procedures
each year.
This survey demonstrated that private surgeons perform fewer free flap operations
than do academic surgeons (Figure 8), and it also showed that private surgeons have
different preferences for flap surveillance (Figure 12). It stands to reason that private
surgeons at low volume centers are likely the best candidates for the adoption of the
capillary blood gas. Furthermore, the simplicity, low cost and reliability of the capillary
blood gas coincide with the preferences indicated by both private and academic
microvascular surgeons in this survey (Figures 13, 14, 15).
Despite technological advances, free tissue transfer still maintains a failure rate
unacceptable to reconstructive surgeons. Post-operative flap surveillance strategies
provide the best opportunity for identifying and salvaging flaps with impaired perfusion.
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To date, there remains no universally accepted post-operative monitoring technique to
complement clinical assessment of the transferred tissue. The field of reconstructive
surgery needs a uniform method of collecting objective and reliable data, one userfriendly enough to be employed with minimal training by ancillary health care staff. In
this study, capillary blood gas proved to be a powerful tool for evaluating impaired
perfusion to a flap because it provides users the ability to simultaneously monitor two
accepted methods of flap surveillance: pO2 and pH, while doing so in an inexpensive and
reliable manner. The finding that the simple CBG is a useful monitoring tool carries
significant weight and should merit further evaluation in humans.
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APPENDICES
Appendix 1.
Oral Cavity and Oropharynx
Tis
T1
T2
T3
T4a
T4b

Carcinoma is in situ
Tumor is 2 cm or less in greatest dimension
Tumor is more than 2 cm but not greater than 4 cm in greatest dimension
Tumor is more than 4 cm in greatest dimension
Tumor invades adjacent structures: cortical bone, muscle of tongue, larynx, medial
pterygoid, hard palate or mandible
Tumor invades masticator space, pterygoid plates, or skull base and/or encases the
internal carotid artery

Supraglottis
T1
T2
T3
T4a
T4b

Tumor is limited to one subsite of the supraglottis, with normal vocal cord mobility
Tumor invades mucosa of more than one adjacent subsite of the supraglottis or glottis,
without fixation of the larynx
Tumor is limited to the larynx with vocal cord fixation and/or invades the postcricoid
area, pre-epiglottic tissues, paraglottic space and/or thyroid cartilage erosion
Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx
(trachea, soft tissues of neck, strap muscles, thyroid, esophagus)
Tumor invades prevertebral space, encases the carotid or invades the mediastinum

Glottis
T1
T2
T3
T4a
T4b

Tumor is limited to the vocal cords with normal mobility
Tumor extends to the supraglottis and/or subglottis and/or with impaired vocal cord
mobility
Tumor is limited to the larynx with vocal cord fixation and/or invades paraglottic
space, and or minor thyroid cartilage erosion
Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx
(trachea, soft tissues of the neck, strap muscles, thyroid, or esophagus)
Tumor invades prevertebral space, encases the carotid or invades the mediastinum

Subglottis
T1
T2
T3
T4a
T4b

Tumor is limited to the subglotttis
Tumor extends to the vocal cord(s), with normal or impaired mobility
Tumor is limited to the larynx, with vocal cord fixation
Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx
(trachea, soft tissues of the neck, strap muscles, thyroid, or esophagus)
Tumor invades prevertebral space, encases the carotid or invades the mediastinum

Hypopharynx
T1
T2

T3
T4a
T4b

Tumor is limited to one subsite of the hypopharynx and 2cm or less in dimension
Tumor invades more than one subsite of the hypopharynx or an adjacent site, or
measures more than 2 cm but not more than 4 cm in greatest dimension without
fixation of the hemilarynx
Tumor is more than 4 cm in greatest dimension or with fixation of the hemilarynx
Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus, or
central compartment soft tissue
Tumor invades prevertebral fascia, encases the carotid or involves the mediastinum

32
Lymph Node Staging for Oral Cavity, Oropharynx, Hypopharynx and all Glottic Cancer
N0
N1
N2

N2a
N2b
N2c
N3

There is no regional nodes metastasis
Metastasis is in a single ipsilateral lymph node, 3cm or less in greatest dimension
Metastasis is in a single ipsilateral lymph node, more than 3 cm but not more than 6
cm in greatest dimension, or metastasis is in multiple ipsilateral lymph nodes, none
more than 6 cm in greatest dimension or bilateral or contralateral lymph nodes
(although less than 6 cm)
Metastasis is in a single ipsilateral lymph node, more than 3 cm but not more than 6
cm
Metastasis is in multiple ipsilateral lymph nodes, none more than 6 cm in greatest
dimension
Metastasis is in bilateral or contralateral lymph nodes, none more than 6 cm
Metastasis is in a lymph node more than 6 cm in greatest dimension

Stage Grouping
Stage 0
Stage I
Stage II
Stage III

Stage IVA

Stage IVB
Stage IVC

Tis
T1
T2
T3
T1
T2
T3
T4a
T4a
T1
T2
T3
T4a
T4b
Any T
Any T

N0
M0
N0
M0
N0
M0
N0
M0
N1
M0
N1
M0
N1
M0
N0
M0
N1
M0
N2
M0
N2
M0
N2
M0
N2
M0
Any N M0
N3
M0
Any N M1
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Appendix 2.
Yale Free Flap Monitoring Survey
1.

Which of the following clinical assessment techniques do you use to assess cutaneous free flap
viability post-operatively? (Select all that apply)
Capillary refill
Flap Color
Skin Turgor
Tissue Edema
I do not rely on clinical assessment of flap viability
Other
Comments:

2.

Which of the following objective measures do you use in assessing flap viability postoperatively?
(Select all that apply)
Implantable Doppler Cuff at vascular pedicle
Intravenous Sodium Fluorescein monitoring
Lancet (prick) and Bleeding
Microdialysis
Muscle contractility testing
Non-Invasive Laser Doppler Ultrasonography
Photoplethysmograph
Plethysmograph
Pulse Oximetry
Temperature monitoring
Transcutaneous O2 monitoring
Tissue Oxygen Tension (microelectrodes)
Tissue pH monitoring
Tissue Spectrophotometry
Other:
Comments:

3.

Are clinical assessment techniques or objective measures more important to you in making the
decision to re-explore the vascular pedicle in a threatened flap?
Clinical assessment
Objective Tests
Comments:

4.

Would you be open to using a different objective monitoring technique?
Yes
No

5.

Is the expense of objective monitoring techniques a consideration in your choice of instruments?
Yes
No
Is staff training a barrier to the use of newer, free flap objective monitoring technologies?
Yes
No

6.

7.

Any other comments about post operative monitoring of free tissue flaps:
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DATA TABLES
Table 1. Oxygen Microelectrode Measurements Obtained After Vein or Artery Clamping
Measure
Oxygen tension (mmHg)

Vein (n=3)

Artery (n=2)

Before Clamp
5 Minutes
10 Minutes
15 Minutes

28.53
23.73
17.5
16.26

18.85
6.56
7.57
8.47

Before Clamp
5 Minutes
10 Minutes
15 Minutes

317
288
280
249

497
153
119
148

Blood Flow (LDF)

Table 2. Capillary Blood Gas Measurements Obtained After Vein Clamping: Mean +/- 1
Standard Deviation
Vein Clamp
(n=8)

Time

pO2 (mmHg)

pH

pCO2 (mmHg)

HCO3

Before clamp

42.71 (+/- 5.12)

7.38 (+/- 0.04)

41.13 (+/-7.68)

23.38 (+/- 3.11)

10 Minutes

31.57 (+/- 7.83)

7.33 (+/- 0.05)

39.00 (+/- 9.80)

21.16 (+/- 3.66)

20 minutes

28.67 (+/- 6.28)

7.30 (+/- 0.04)

43.50 (+/- 11.20)

21.17 (+/- 6.11)

Table 3. Statistical analysis of changes in Capillary Blood Gas measurements from
control at 10 and 20 minutes following venous clamping using the paired t-test.
Time Interval
Time 0-10 min

Statistical Value

pO2 (mmHg)

pH

pCO2

HCO3

p value
DF
95% CI

*0.014
5
(3.74, 20.26)

*0.024
6
(0.0008, 0.080)

0.539
6
(-5.51, 9.51)

0.227
6
(-1.51, 5.20)

p value
DF
95% CI

*<0.001
4
(14.72, 22.08)

*0.032
5
(0.01, 0.16)

0.65
0.523
5
5
(-20.26, 13.93) (-5.59, 10.28)

Time 0-20 min

*p<0.05, DF=degrees of freedom, CI=confidence interval

35
FIGURES

Figure 1
A typical recording performed with the Bare-Fibre Oxygen
Microelectrode showing oxygen tension (pO2, mm Hg) and flow (perfusion units)
before, during and after venous clamping
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Figure 2
A typical recording performed with the Bare-Fibre Oxygen
Microelectrode showing oxygen tension (pO2, mm Hg) and flow (perfusion units)
before, during, and after arterial clamping.

37

38
Figure 5.

Figure 6.

Figure 7.
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Figure 8.

Figure 9.

Figure 10.
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Figure 11.

Figure 12.

Figure 13.
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Figure 14.

Figure 15.
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